Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth

International Journal of Oncology
Yuan LiuXiaoping Wan

Abstract

In order to improve the sensitivity of cervical cancer cells to irradiation therapy, we targeted hexokinase 2 (HK2), the first rate-limiting enzyme of glycolysis, and explore its role in cervical cancer cells. We suppressed HK2 expression and/or function by shRNA and/or metformin and found HK2 inhibition enhanced cells apoptosis with accelerating expression of cleaved PARP and caspase-3. HK2 inhibition also induced much inferior proliferation of cervical cancer cells both in vitro and in vivo with diminishing expression of mTOR, MIB and MGMT. Moreover, HK2 inhibition altered the metabolic profile of cervical cancer cells to one less dependent on glycolysis with a reinforcement of mitochondrial function and an ablation of lactification ability. Importantly, cervical cancer cells contained HK2 inhibition displayed more sensitivity to irradiation. Further results indicated that HPV16 E7 oncoprotein altered the glucose homeostasis of cervical cancer cells into glycolysis by coordinately promoting HK2 expression and its downregulation of glycolysis. Taken together, our findings supported a mechanism whereby targeting HK2 inhibition contributed to suppress HPV16 E7-induced tumor glycolysis metabolism phenotype, inhibiting tumor growt...Continue Reading

References

Sep 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·E Bustamante, P L Pedersen
Dec 26, 2001·The Journal of Biological Chemistry·John G PastorinoJan B Hoek
Mar 9, 2005·Trends in Biochemical Sciences·Jung-Whan Kim, Chi V Dang
Jun 13, 2006·Cancer Cell·Thi Bui, Craig B Thompson
Sep 23, 2006·Nature Reviews. Cancer·Richard Roden, T-C Wu
Apr 19, 2007·Cancer Metastasis Reviews·Benjamin J MoellerMark W Dewhirst
Oct 11, 2007·Science's STKE : Signal Transduction Knowledge Environment·Gregg L Semenza
May 31, 2008·Nature Reviews. Cancer·Michael BaumannRichard Hill
Jun 10, 2008·Cancer Cell·Guido Kroemer, Jacques Pouyssegur
Sep 9, 2008·Cell·Peggy P Hsu, David M Sabatini
Mar 27, 2009·Virology·Mitsuhiro NakamuraLaimonis A Laimins
May 30, 2009·Nature Reviews. Drug Discovery·Dunyaporn TrachoothamPeng Huang
Jun 13, 2009·Current Molecular Medicine·Sara RockwellVan Thuc Vu
Aug 20, 2009·Mini Reviews in Medicinal Chemistry·Alvaro Marín-HernándezRafael Moreno-Sánchez
Oct 8, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Emma BoldersonKum Kum Khanna
Nov 10, 2009·International Journal of Radiation Biology·Ulrike G A Sattler, Wolfgang Mueller-Klieser
Nov 21, 2009·Actas urologicas españolas·Avelino FragaRui Medeiros
Sep 18, 2010·Journal of Experimental & Clinical Cancer Research : CR·Peng Guo-QingTian Yan
Jan 19, 2011·The Journal of Experimental Medicine·Amparo WolfAbhijit Guha
Aug 26, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Miguel A Peña-RicoAnna Manzano
Nov 16, 2011·Cancer Research·Franziska HirschhaeuserWolfgang Mueller-Klieser
Apr 3, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael MilosevicRobert Bristow
Jul 10, 2013·The Journal of Biological Chemistry·David J RobertsShigeki Miyamoto
Feb 22, 2014·Gynecologic Oncology·Nader Husseinzadeh, Holleh D Husseinzadeh

❮ Previous
Next ❯

Citations

Jun 23, 2018·International Journal of Molecular Sciences·Imelda Martínez-RamírezMarcela Lizano
Dec 14, 2018·Current Medicinal Chemistry·Sara N GarciaM Matilde Marques
Nov 14, 2019·Cancer Cell International·Liang MaZhixiang Zhuang
Jan 2, 2018·Oncotarget·Karin Hoppe-SeylerFelix Hoppe-Seyler
Nov 19, 2019·Frontiers in Oncology·Karen G de la Cruz-LópezJoaquín Manzo-Merino
Jun 28, 2019·Current Protein & Peptide Science·Eskandar TaghizadehSeyed Mohammad Gheibi Hayat
Oct 17, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sameer AgnihotriGelareh Zadeh
Feb 26, 2021·Technology in Cancer Research & Treatment·Shanqiang Zhan, Baoliang Ni
Aug 17, 2020·Life Sciences·Vaishali ChandelDhruv Kumar
Nov 24, 2020·The European Journal of Neuroscience·Angeliki-Maria VlaikouMichaela D Filiou
Jul 1, 2021·Life Sciences·Shalini ManiKeshav K Singh
Aug 10, 2021·Frontiers in Oncology·Kevin X LiuMichael G Milligan
Sep 29, 2021·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yuan FangDehua Wu
Dec 10, 2021·Cell Biology International·Shikai LiuLiang Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
flow cytometry
xenograft

Software Mentioned

SAS
Excel
R

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.